ResMed Inc (RMD)
245.66
+2.05
(+0.84%)
USD |
NYSE |
Nov 05, 16:00
243.64
-2.02
(-0.82%)
After-Hours: 18:59
ResMed Cash from Operations (Quarterly): 325.54M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 325.54M |
| June 30, 2024 | 440.11M |
| March 31, 2024 | 402.03M |
| December 31, 2023 | 272.83M |
| September 30, 2023 | 286.28M |
| June 30, 2023 | 237.44M |
| March 31, 2023 | 282.56M |
| December 31, 2022 | 128.64M |
| September 30, 2022 | 44.66M |
| June 30, 2022 | 79.49M |
| March 31, 2022 | 117.44M |
| December 31, 2021 | 219.88M |
| September 30, 2021 | -65.66M |
| June 30, 2021 | 226.52M |
| March 31, 2021 | 196.28M |
| December 31, 2020 | 169.92M |
| September 30, 2020 | 144.00M |
| June 30, 2020 | 330.26M |
| March 31, 2020 | 239.70M |
| December 31, 2019 | 69.93M |
| September 30, 2019 | 162.36M |
| June 30, 2019 | 141.82M |
| March 31, 2019 | 139.65M |
| December 31, 2018 | 129.47M |
| September 30, 2018 | 48.12M |
| Date | Value |
|---|---|
| June 30, 2018 | 129.42M |
| March 31, 2018 | 149.08M |
| December 31, 2017 | 132.55M |
| September 30, 2017 | 93.98M |
| June 30, 2017 | 140.31M |
| March 31, 2017 | 67.60M |
| December 31, 2016 | 119.90M |
| September 30, 2016 | 86.24M |
| June 30, 2016 | 142.96M |
| March 31, 2016 | 124.75M |
| December 31, 2015 | 155.61M |
| September 30, 2015 | 124.61M |
| June 30, 2015 | 99.70M |
| March 31, 2015 | 90.94M |
| December 31, 2014 | 106.00M |
| September 30, 2014 | 86.54M |
| June 30, 2014 | 115.58M |
| March 31, 2014 | 101.10M |
| December 31, 2013 | 84.16M |
| September 30, 2013 | 90.42M |
| June 30, 2013 | 123.92M |
| March 31, 2013 | 107.00M |
| December 31, 2012 | 93.65M |
| September 30, 2012 | 78.25M |
| June 30, 2012 | 96.98M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-65.66M
Minimum
Sep 2021
440.11M
Maximum
Jun 2024
207.39M
Average
223.20M
Median
Cash from Operations (Quarterly) Benchmarks
| Boston Scientific Corp | 1.002B |
| Abbott Laboratories | 2.705B |
| Becton Dickinson & Co | 1.263B |
| Insulet Corp | 96.50M |
| Twist Bioscience Corp | -6.378M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.146M |
| Cash from Financing (Quarterly) | -150.76M |
| Free Cash Flow | 1.347B |
| Free Cash Flow Per Share (Quarterly) | 2.073 |
| Free Cash Flow to Equity (Quarterly) | 335.67M |
| Free Cash Flow to Firm (Quarterly) | 307.28M |
| Free Cash Flow Yield | 3.72% |